Centre Hospitalier Universitaire de Caen
Centre Hospitalier Universitaire de Caen
Caen, France3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis. | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Recruiting | Phase 3 | 2026-02-02 | NCT05758831 | |
| Treatment of Brain AVMs (TOBAS) Study | Aneurysm, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriovenous hemangioma/malformation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder, vascular malformation | Recruiting | Not applicable | 2024-08-15 | NCT02098252 | |
| Lung Cancer Screening in a Population Exposed to Occupational Lung Carcinogens | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2024-07-09 | NCT03562052 |